trending Market Intelligence /marketintelligence/en/news-insights/trending/ft12liGfIhzzbxmxQFesxg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Summit Healthcare board recommends against mini-tender offer

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate (CRE) Sector Feels the Impact of the Coronavirus

Credit Analytics Case Study Poundworld Retail Ltd


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Summit Healthcare board recommends against mini-tender offer

Summit Healthcare REIT Inc.'s board urged shareholders to reject an unsolicited mini-tender offer to purchase Summit shares by MacKenzie Realty Capital and its affiliates.

MacKenzie is offering to buy up to 330,000 Summit shares for roughly $1.34 apiece, a price which the board believes is lower than the current and potential long-term value of the company's shares.

The company's most recent estimated valuation, as of Dec. 31, 2016, stood at $2.53 per share.

The board also noted in its letter to shareholders that MacKenzie previously made similar mini-tender offers in 2016.